Hanmi Pharmaceutical Builds Domestic Chatbot Infrastructure for Digital Healthcare Platform 'eppiday'

What happened

Hanmi Pharmaceutical, a Korean drugmaker, signed a memorandum of understanding (MOU, a basic agreement to work together) with three partners. The partners are FuriosaAI, which makes AI chips; Xpferix, which makes AI solutions; and Bagel Labs, a health care unit of Xpferix. The goal is to move the eppiday chatbot to a Korean-style large language model (LLM, the kind of AI that writes text) and to build AI systems in Korea.

What eppiday does

Eppiday is a digital health service. Users enter health information and a questionnaire, and the app gives personal health tips. Users can track weight, meals, and exercise. An AI health coach helps with things like obesity treatment. The company says the main goal is to help people build healthy habits, not just answer simple questions.

Key facts

• Hanmi Pharmaceutical is the service owner. It sets the overall direction and priorities.
• Bagel Labs builds the app and chatbot, swaps in new AI models, and checks answer quality.
• Xpferix sets up and runs Korean AI servers and provides the Korean LLM environment.
• FuriosaAI supplies Korean AI chips and helps optimize the models.
• The four companies have already tested in a test setting that the AI coaching answers can run on domestic servers.

Why it matters

Health data is sensitive, so where it is stored and processed matters a lot. By moving from overseas cloud servers to Korean systems, Hanmi hopes to keep more control over patient data. The company also hopes to make costs more predictable as the number of users grows.

What to watch

• When the new system will be used in the real service has not been set yet. It depends on quality and safety checks.
• The four companies are still comparing answer accuracy and response speed before and after the switch.
• Hanmi plans to first switch the coaching answer feature, then replace other features such as drug and food search and meal photo recognition.